AGL 40.22 Increased By ▲ 0.22 (0.55%)
AIRLINK 127.00 Decreased By ▼ -0.04 (-0.03%)
BOP 6.62 Decreased By ▼ -0.05 (-0.75%)
CNERGY 4.51 No Change ▼ 0.00 (0%)
DCL 8.61 Increased By ▲ 0.06 (0.7%)
DFML 41.65 Increased By ▲ 0.21 (0.51%)
DGKC 87.00 Increased By ▲ 0.15 (0.17%)
FCCL 32.35 Increased By ▲ 0.07 (0.22%)
FFBL 65.25 Increased By ▲ 0.45 (0.69%)
FFL 10.19 Decreased By ▼ -0.06 (-0.59%)
HUBC 110.00 Increased By ▲ 0.43 (0.39%)
HUMNL 14.65 Decreased By ▼ -0.03 (-0.2%)
KEL 5.13 Increased By ▲ 0.08 (1.58%)
KOSM 7.53 Increased By ▲ 0.07 (0.94%)
MLCF 41.52 Increased By ▲ 0.14 (0.34%)
NBP 59.60 Decreased By ▼ -0.81 (-1.34%)
OGDC 194.70 Increased By ▲ 4.60 (2.42%)
PAEL 28.20 Increased By ▲ 0.37 (1.33%)
PIBTL 7.82 Decreased By ▼ -0.01 (-0.13%)
PPL 152.60 Increased By ▲ 2.54 (1.69%)
PRL 26.60 Decreased By ▼ -0.28 (-1.04%)
PTC 16.10 Increased By ▲ 0.03 (0.19%)
SEARL 79.50 Decreased By ▼ -6.50 (-7.56%)
TELE 7.47 Decreased By ▼ -0.24 (-3.11%)
TOMCL 35.42 Increased By ▲ 0.01 (0.03%)
TPLP 8.25 Increased By ▲ 0.13 (1.6%)
TREET 16.08 Decreased By ▼ -0.33 (-2.01%)
TRG 52.75 Decreased By ▼ -0.54 (-1.01%)
UNITY 26.79 Increased By ▲ 0.63 (2.41%)
WTL 1.25 Decreased By ▼ -0.01 (-0.79%)
BR100 9,941 Increased By 56.9 (0.58%)
BR30 30,902 Increased By 301.8 (0.99%)
KSE100 93,790 Increased By 434.4 (0.47%)
KSE30 29,067 Increased By 136.1 (0.47%)

Professor Dr Khalid M Khan senior scientist in the Karachi University's International Center for Chemical and Biological Sciences (ICCBS), has been nominated for Sitara-e- Imtiaz here on Saturday. Dr Khan is among the most prominent researchers of Pakistan.
He was awarded Justice Qadeeruddin Gold Medal in 2003 and Pakistan Academy of Sciences Gold Medal in 2004. The President of Pakistan has awarded Tamgha-i-Imtiaz in recognition of his research work in the field of bio-organic and medicinal chemistry in the year 2004. He is working in HEJ Research Institute of Chemistry since 1987.
He is currently working as a professor in HEJ Research Institute. The major emphasis of his work is on the synthesis of inhibitors of clinically important enzymes. He currently identified a number of new lead compounds, which are active against leishmaniasis (Kala- Azar) and peptic ulcer.

Copyright Business Recorder, 2011

Comments

Comments are closed.